Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)
China flag China · Delayed Price · Currency is CNY
30.19
-0.71 (-2.30%)
Mar 19, 2026, 3:00 PM CST

SHA:688321 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-114.5788.8417.4821.96
Depreciation & Amortization
59.0343.7338.7219.62
Other Amortization
2.461.893.741.65
Loss (Gain) From Sale of Assets
-0-0.710.13
Asset Writedown & Restructuring Costs
90.120.03--
Loss (Gain) From Sale of Investments
21.6-282.03-2.4-5.52
Provision & Write-off of Bad Debts
-2.694.330.550.05
Other Operating Activities
17.73-22.07112.12
Change in Accounts Receivable
-19.62-59.12-42.46-73.72
Change in Inventory
6.29-18.66-19.41-1.1
Change in Accounts Payable
3.0849.7542.64182.88
Change in Other Net Operating Assets
-3.37-10.02-4.64-4.59
Operating Cash Flow
76.13-157.2743.3124.78
Operating Cash Flow Growth
---65.30%33.29%
Capital Expenditures
-268.49-229.03-400.17-288.46
Sale of Property, Plant & Equipment
00.450.290.01
Divestitures
--41.35--
Investment in Securities
-40.47-119.14-407.46245.55
Other Investing Activities
12.9214.065.6312.28
Investing Cash Flow
-296.03-375.01-801.7-30.62
Long-Term Debt Issued
408.19444.21541174.92
Long-Term Debt Repaid
-190.19-221.73-260.34-96.55
Net Debt Issued (Repaid)
217.99222.48280.6678.37
Issuance of Common Stock
-178.88488.3418.01
Repurchase of Common Stock
-15---154.59
Common Dividends Paid
-27.63-18.74-12.17-4.22
Other Financing Activities
--104.46-0.89
Financing Cash Flow
175.36382.62861.29-63.31
Foreign Exchange Rate Adjustments
0.391.0812.23-2.25
Net Cash Flow
-44.15-148.58115.1128.6
Free Cash Flow
-192.36-386.3-356.87-163.68
Free Cash Flow Margin
-29.24%-73.76%-67.34%-38.03%
Free Cash Flow Per Share
-0.47-0.95-0.88-0.40
Cash Income Tax Paid
27.6840.02-7.914.06
Levered Free Cash Flow
-223.51-507.91-232.05-292.18
Unlevered Free Cash Flow
-202.11-486.11-219.46-289.23
Change in Working Capital
2.448-26.5184.77
Source: S&P Global Market Intelligence. Standard template. Financial Sources.